Nanocarriers Usage for Drug Delivery in Cancer Therapy

Conventional therapeutic agents have displayed significant shortcomings. For this reason, important achievements have effectively made in biotechnology for delivering the therapeutic agents to the site of action, and diminish side effects. Polymeric carriers, micelles, dendrimers, liposomes, solid l...

Descripción completa

Detalles Bibliográficos
Autores principales: Khodabandehloo, Hadi, Zahednasab, Hamid, Ashrafi Hafez, Asghar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shahid Beheshti University of Medical Sciences 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951761/
https://www.ncbi.nlm.nih.gov/pubmed/27482328
http://dx.doi.org/10.17795/ijcp-3966
_version_ 1782443762982584320
author Khodabandehloo, Hadi
Zahednasab, Hamid
Ashrafi Hafez, Asghar
author_facet Khodabandehloo, Hadi
Zahednasab, Hamid
Ashrafi Hafez, Asghar
author_sort Khodabandehloo, Hadi
collection PubMed
description Conventional therapeutic agents have displayed significant shortcomings. For this reason, important achievements have effectively made in biotechnology for delivering the therapeutic agents to the site of action, and diminish side effects. Polymeric carriers, micelles, dendrimers, liposomes, solid lipid carriers, gold carriers, viral carriers, nanotubes and magnetic carriers incorporating cytotoxic therapeutics have developed. To improve biological distribution of therapeutic drugs, some modified carriers have designed in optimal size and modified surface area. Delivery of carriers to target cells could be done by passive and active targeting.
format Online
Article
Text
id pubmed-4951761
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Shahid Beheshti University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-49517612016-08-01 Nanocarriers Usage for Drug Delivery in Cancer Therapy Khodabandehloo, Hadi Zahednasab, Hamid Ashrafi Hafez, Asghar Iran J Cancer Prev Review Article Conventional therapeutic agents have displayed significant shortcomings. For this reason, important achievements have effectively made in biotechnology for delivering the therapeutic agents to the site of action, and diminish side effects. Polymeric carriers, micelles, dendrimers, liposomes, solid lipid carriers, gold carriers, viral carriers, nanotubes and magnetic carriers incorporating cytotoxic therapeutics have developed. To improve biological distribution of therapeutic drugs, some modified carriers have designed in optimal size and modified surface area. Delivery of carriers to target cells could be done by passive and active targeting. Shahid Beheshti University of Medical Sciences 2016-04-24 /pmc/articles/PMC4951761/ /pubmed/27482328 http://dx.doi.org/10.17795/ijcp-3966 Text en Copyright © 2016, Iranian Journal of Cancer Prevention http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
spellingShingle Review Article
Khodabandehloo, Hadi
Zahednasab, Hamid
Ashrafi Hafez, Asghar
Nanocarriers Usage for Drug Delivery in Cancer Therapy
title Nanocarriers Usage for Drug Delivery in Cancer Therapy
title_full Nanocarriers Usage for Drug Delivery in Cancer Therapy
title_fullStr Nanocarriers Usage for Drug Delivery in Cancer Therapy
title_full_unstemmed Nanocarriers Usage for Drug Delivery in Cancer Therapy
title_short Nanocarriers Usage for Drug Delivery in Cancer Therapy
title_sort nanocarriers usage for drug delivery in cancer therapy
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951761/
https://www.ncbi.nlm.nih.gov/pubmed/27482328
http://dx.doi.org/10.17795/ijcp-3966
work_keys_str_mv AT khodabandehloohadi nanocarriersusagefordrugdeliveryincancertherapy
AT zahednasabhamid nanocarriersusagefordrugdeliveryincancertherapy
AT ashrafihafezasghar nanocarriersusagefordrugdeliveryincancertherapy

Ejemplares similares